NCT00912067

Brief Summary

The purpose of this study is to evaluate the presence and manifestations of ocular graft versus host disease in adults that had hematopoietic stem cell transplantation in the past 3 years at the sheba medical center, Israel. As well as correlate the degree of the presentation to the therapeutic protocol (chemotherapy and irradiation).

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 1, 2009

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 3, 2009

Completed
28 days until next milestone

Study Start

First participant enrolled

July 1, 2009

Completed
Last Updated

June 3, 2009

Status Verified

June 1, 2009

First QC Date

June 1, 2009

Last Update Submit

June 1, 2009

Conditions

Graft Versus Host Disease

Study Arms (1)

hematopoietic stem cell transplantation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

adults after hematopoietic stem cell transplantation done at sheba medical center Israel during the last 3 years

You may qualify if:

  • after hematopoietic stem cell transplantation done at sheba medical center Israel
  • month have past from transplantation but no more then 3 years

You may not qualify if:

  • transplantation done in the last 3 month or more than 3 years have past since

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sheba Medical Center

Tel Litwinsky, 52621, Israel

Location

Related Publications (2)

  • Kim SK. Update on ocular graft versus host disease. Curr Opin Ophthalmol. 2006 Aug;17(4):344-8. doi: 10.1097/01.icu.0000233952.09595.d8.

    PMID: 16900025BACKGROUND

  • Anderson NG, Regillo C. Ocular manifestations of graft versus host disease. Curr Opin Ophthalmol. 2004 Dec;15(6):503-7. doi: 10.1097/01.icu.0000143684.22362.46.

    PMID: 15523196BACKGROUND

MeSH Terms

Conditions

Graft vs Host Disease

Condition Hierarchy (Ancestors)

Immune System Diseases

Study Officials

  • irina barequet, MD

    Sheba Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER GOV

Study Record Dates

First Submitted

June 1, 2009

First Posted

June 3, 2009

Study Start

July 1, 2009

Last Updated

June 3, 2009

Record last verified: 2009-06

Locations

IL(1)